CSI Market
Sign In | Register

Theravance Biopharma inc (TBPH) Annual Balance Sheets

Annual · GAAP · USD millions
Access TBPH quarterly Balance Sheets →
The data below summarizes Theravance Biopharma inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent167.81
Available-for-sale Securities, Debt Securities, Current MA147.55
Cash & Short-term Investments314.00
Due from Related Parties, Current RE0.00
Other Current Assets95.54
Other Prepaid Expense, Current PR7.56
Total Current Assets418.46
Equipment/Property/Plant Net5.90
Long-term investments11.13
Income Taxes Receivable, Noncurrent0.00
Other Assets, Noncurrent61.22
Receivables From Collaboration Partners45.54
Operating Lease Right Of Use Asset24.37
Total Assets485.57
Liabilities
Accounts Payable, Current AC2.57
Employee-related Liabilities, Current AC12.59
Other Liabilities, Current17.86
Accrued Income Taxes, Current TA5.29
Total Current Liabilities38.30
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.00
Accrued Clinical And Development Expenses Current3.37
Accrued General And Administrative Expenses2.05
Operating Lease Liability Current10.95
Operating Lease Liability Noncurrent31.76
Future Royalty Payment Contingencies32.80
Unrecognized Tax Benefits Total-
Contract With Customer Liability Noncurrent-
Total Liabilities38.30
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,156.29
Retained Earnings / Accumulated Deficit-859.63
Accumulated Other Comprehensive Income0.00
Other Equity0.06
Common Stockholder's Equity296.72
Total Stockholder's Equity296.72
Liabilities & Stockholder's Equity485.57
4 historic quarters locked

Sign in to unlock the full Theravance Biopharma inc balance sheet history.

Sign In Create Free Account

About Theravance Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-033077

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License